SCHEMBL5470601

SCHEMBL5470601

O=C(O)/C=C/c1ccc(O)c(O)c1CCc1ccc(O)c(O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 2/20 0.48
APP P05067 4/20 0.46
KDM4E B2RXH2 3/20 0.46
HSD17B10 Q99714 3/20 0.46
CA2 P00918 3/20 0.46
CA4 P22748 3/20 0.46
NFKB1 P19838 3/20 0.46
CA12 O43570 2/20 0.46
CA7 P43166 2/20 0.46
LMNA P02545 2/20 0.46
POLB P06746 2/20 0.46
GAA P10253 2/20 0.46
MAPT P10636 2/20 0.46
HPGD P15428 2/20 0.46
APEX1 P27695 2/20 0.46
PMP22 Q01453 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
TSHR P16473 2/20 0.46
HIF1A Q16665 2/20 0.46
CA1 P00915 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10339405 1.00 LCK (0.48) LCKAPPKDM4EHSD17B10CA2
SCHEMBL5464966 0.87 MIF (0.44) CA2CA4NFKB1CA12CA7
SCHEMBL15419981 0.86 NFKB1 (0.50) LCKAPPKDM4EHSD17B10CA2
SCHEMBL29065702 0.86 NFKB1 (0.50) LCKAPPKDM4EHSD17B10CA2
SCHEMBL5463214 0.84 AKR1B1 (0.46) LCKAPPKDM4EHSD17B10CA2
SCHEMBL26046327 0.81 CA1 (0.49) APPKDM4EHSD17B10CA2CA4
SCHEMBL28249242 0.80 ESR1 (0.49) APPKDM4EHSD17B10CA2CA4
SCHEMBL6668620 0.76 ESR1 (0.48) APPKDM4EHSD17B10CA2CA4
SCHEMBL6678566 0.76 ESR1 (0.48) APPKDM4EHSD17B10CA2CA4
SCHEMBL18900158 0.76 CA1 (0.47) APPKDM4EHSD17B10CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9089499-B2 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions UNIVERSITE JOSEPH FOURIER-GRENOBLE 1 (FR) 2015-07-28 US disclosed
US-20130272983-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and their Use in Cosmetic or Dermatological Compositions Universite Joseph Fourier-Grenoble 1. (FR) 2013-10-17 US disclosed
US-20070183996-A1 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S. (FR) 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070183996-A1 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions TYR, CUTA, HPD LCK 3991/4885APP 2180/4885KDM4E 1196/4885
US-20130272983-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and their Use in Cosmetic or Dermatological Compositions TYR, CUTA, HPD LCK 3991/4885APP 2180/4885KDM4E 1196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.